Rituximab, bendamustine and cytarabine (R‐BAC) in patients with relapsed‐refractory aggressive B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25278
Abstract: and bone marrow mast cell burden (Table 1). Next, we focused on SM-AHN-myeloid (n = 178), which included 11 (6%) patients with SM associated with acute myeloid leukemia (SM-AML), 50 (28%) patients with SM associated… read more here.
Keywords: cell; patients associated; ahn myeloid; mds mpn ... See more keywords